A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. - Wikidata - awgldk - TriplyDB

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

http://www.wikidata.org/entity/Q34071175

about

Cancer pharmacogenomics: strategies and challenges Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype Genome-wide association study identifies multiple loci associated with bladder cancer risk Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3 A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai.SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib.Multiple loci are associated with white blood cell phenotypes.Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background.Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes.A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestry Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway.Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions TACC3 is essential for EGF-mediated EMT in cervical cancer MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44 Genetic variation in DROSHA 3'UTR regulated by hsa-miR-27b is associated with bladder cancer risk.Prognostic relevance of urinary bladder cancer susceptibility loci.Genetic susceptibility to bladder cancer risk and outcome.European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.The post GWAS era: strategies to identify gene-gene and gene-environment interactions in urinary bladder cancer.High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.Functional POR A503V is associated with the risk of bladder cancer in a Chinese population.Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population.Personal hair dye use and the risk of bladder cancer: a case-control study from The Netherlands.A prospective multicenter study on bladder cancer: the COBLAnCE cohort.Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation.Highlight report: Functional consequences of urinary bladder cancer risk variants.Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry.Bladder cancer epidemiology and genetic susceptibility.Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms?

P2860

Q24289309-2A85A8FE-CEC0-4057-98B5-1EBC775039C9 Q28259472-4D52E786-40CF-4056-9135-4D1B4BDF159D Q28393844-348BF780-85D4-4668-BBFD-FB7F00D7F4AB Q28395447-009CAA69-8B82-42FF-B427-901CCFC14A56 Q28659283-5DDB3087-5242-4B89-8AE4-4548151C30AB Q28943326-54B8E0D3-CE42-4B4A-A434-B99EF7D22F2A Q28943348-DE8D6A2B-270F-4F4F-81CA-230FFE30E9DF Q28943367-0BED0410-94D8-46FE-9299-B1FDE6B6B6B7 Q33566957-E65C1BC0-D0D3-43B5-BAF5-7E504CDF0478 Q33591054-4F65CCEC-02C0-42F9-8219-AE4747DAAD9A Q33738889-347AF530-6E37-468D-B043-66DB1F15868D Q33954440-B53C8417-9F74-4643-94CD-AFE6D97C906F Q34125066-28B4E1AF-7ECE-4376-8437-93D24254A406 Q34152192-85F12CD6-F326-486A-AF5F-C6E9DABB34E4 Q34353049-7803E3E8-2DFA-4DF2-8082-59DD68280C6D Q34375736-6C59EAA5-0C8E-4ECE-8BB4-322D5906D16F Q34532463-1D4B3635-344F-40F3-9AC3-BB95131F052D Q34662199-20B17C2B-B321-4BED-80C8-998164AAE27A Q34684888-906E8231-7DFC-4303-9D94-58A0E97E20FF Q34762342-546BD62E-32D6-4152-BD4D-C9F708A1D19D Q34925509-CFD9CDD7-3AC0-4D18-81A8-1BCE3E7504E6 Q35030251-23F524F0-505B-424A-8A0D-52A4137D8387 Q35060569-18924567-6938-4BC1-A2CC-530A9437F391 Q35106772-8A4C0D0F-0ABA-4A0D-B70B-DEB388F7D893 Q35212792-51998BA5-DC01-4798-9146-0A6AEBEB5143 Q35288237-24E7733F-47BA-494D-B9AC-B6BB542E1526 Q35729161-BE2961B7-6898-4666-8402-729E65C0153E Q35740091-361161DD-D4C1-44BC-BE38-6B4BA3E53D57 Q35796654-10081019-0A3B-4342-A540-C18B6AAF69FF Q35857520-D13A5260-95A0-4A61-8807-4C11094B04AA Q36013527-535C67CE-99FE-49BB-BCF4-3FFA16EAB2EF Q36181457-7B0C2A28-8420-4AD0-84E9-3FCEC3B9FAC9 Q36361883-ADDC13B4-2317-4355-A20F-15F4F7063432 Q36414408-87BD9C1C-9181-41CF-A1D9-594031B05F66 Q36611884-5B7D4DEE-53D0-40EF-A7E4-531A60BF40B5 Q36715495-DC786BB0-C280-4063-9FF3-BDB12E8F566E Q36754771-DA49ACDB-81E2-42F4-85C8-2F4241BE63EC Q36878096-AACA2308-0090-4B0D-B25F-652737462739 Q36944260-FFB8EFE6-8325-44A8-A705-901BC072108A Q37007328-7533E420-B219-49F7-9B84-019C41794BEF

P2860

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

http://www.wikidata.org/entity/Q34071175

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@ast

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@en

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@en-gb

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@nl

type

label

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@ast

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@en

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@en-gb

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@nl

prefLabel

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@ast

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@en

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@en-gb

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@nl

P1433

Q34071175-36FC2DCF-91C7-477F-8280-16B7930615DB

P1476

Q34071175-74A8A7D4-AF73-46A5-86C0-0840B34AFE53

P2093

Q34071175-00DB1AAD-F213-4A16-8B90-3DF1797D2DF7

Q34071175-0FA6FC30-172F-4A5F-88A1-D29A7983EB09

Q34071175-13451581-4854-42CF-A856-831472628CB2

Q34071175-164288AF-25D9-44A3-8B9D-A3BA3D8C36D6

Q34071175-1887E2E9-1CA6-4C23-BFC0-45B581DABF59

Q34071175-1B0F630B-F010-40F7-81B3-B91DCDEEB6E6

Q34071175-24F9726F-53C6-42C6-8A50-5CF745F5EB22

Q34071175-253B6280-224A-4F63-B182-9783E6A4303A

Q34071175-26A6FCD5-92DA-460D-92F9-ACCD1D467C42

Q34071175-26AB81F2-5E81-4355-B6ED-BCF5F3A886A9

P2860

Q34071175-02C83F82-7A0B-4482-B3E3-99F71E4BA940

Q34071175-0320D3E2-E99B-467A-B12E-DA7DA219C7F5

Q34071175-19B17440-7856-42A1-8BE7-8FCCC13CE896

Q34071175-19D44F6C-FBD6-4BE9-BB2F-621FFA036678

Q34071175-1B354DFD-FF0E-4068-B035-C4325EA133E3

Q34071175-288A3E23-EF66-4A13-BAEB-A706DFD42FDB

Q34071175-3D905904-791F-43C1-A873-69249E96BA77

Q34071175-3FB1671B-63E5-4665-A62D-26339FA363BD

Q34071175-417CA2EE-58F1-4C36-ABE1-E6CBA9396717

Q34071175-42DA3159-836C-4F4D-A6F9-04DCA6359D5D

P2888

Q34071175-89283CBA-7078-499A-8CD4-467295AD1AB8

P304

Q34071175-F5B6393E-9DF8-4AA2-8D62-34FAD7AF8E55

P31

Q34071175-54CDCE81-AFF9-4915-8AF3-E55CE9D8CF97

P356

Q34071175-D1469B7A-641F-43AC-8C0C-12A35145957A

P407

Q34071175-D6D6534D-7469-4494-9FFB-E74D101A205C

P433

Q34071175-5570EBB7-FD98-4AA2-A261-1B0753DD8130

P478

Q34071175-03BD5373-7FA5-448B-8AF0-2B19FFC54D26

P50

Q34071175-11C82AED-6B98-472B-BCD6-FA50BA1FA4CC

Q34071175-120A90F4-0604-4F34-959A-C06385F20449

Q34071175-1F30206A-257A-468B-8214-5042A4660BDA

Q34071175-2EB9DF8E-E313-40B7-81E3-73EA47FE42D0

Q34071175-304B6BCF-599F-463D-A235-2DB1082D136A

Q34071175-394BC011-80B6-485B-9BE2-FC741F5E9154

Q34071175-39FAD1B3-49D4-46A6-986C-CD374D2ED059

Q34071175-40684392-B4AE-4B39-87CC-E5C822EEDC0D

Q34071175-46DFDACF-9CFE-472E-8479-2E6142CFA048

Q34071175-4AF9173F-6148-4D94-87AA-3226F536C228

P577

Q34071175-2DA902E9-1CFC-4E71-8D91-675CD89FC070

P698

Q34071175-11641E42-49B7-4C17-B1F4-345BB0302C55

P932

Q34071175-097D8063-42A6-439C-A7B4-0AF4AE403FA1

P356

P1433

Nature Genetics

P1476

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

@en

P2093

Anne J Grotenhuis

http://www.w3.org/2001/XMLSchema#string

Asgeir Sigurdsson

http://www.w3.org/2001/XMLSchema#string

Berta Saez Gutierrez

http://www.w3.org/2001/XMLSchema#string

Carlo Zanon

http://www.w3.org/2001/XMLSchema#string

Carolyn D Hurst

http://www.w3.org/2001/XMLSchema#string

Cecilia Arici

http://www.w3.org/2001/XMLSchema#string

Eirikur Jonsson

http://www.w3.org/2001/XMLSchema#string

Eliane Kellen

http://www.w3.org/2001/XMLSchema#string

Eugene Gurzau

http://www.w3.org/2001/XMLSchema#string

Faye Elliott

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical aspects of the analysis of data from retrospective studies of disease

Genomic control for association studies

Genetics of gene expression and its effect on disease

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease

A common inversion under selection in Europeans

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types

FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer

Distinct microRNA alterations characterize high- and low-grade bladder cancer

Detection of sharing by descent, long-range phasing and haplotype imputation.

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

P2888

P304

415-419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG.558

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Gudmar Thorleifsson

Unnur Þorsteinsdóttir

Daniel F Gudbjartsson

Carlotta Sacerdote

P577

2010-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20348956

http://www.w3.org/2001/XMLSchema#string

P932

2923020

http://www.w3.org/2001/XMLSchema#string